Among those, 17 made the ROL100 Ranking, which was published June 6 by Indiggo in partnership with Fortune. The ranking is described as an “outside-in” assessment of ReturnOnLeadership for the 100 largest companies in the U.S. (based on the latest Fortune 500 list).
Analysts use publicly available information to examine leadership value creation for each company. This is “a measure of organizational leadership that reflects a comprehensive, industry agnostic framework,” according to the Indiggo website. It is based on four fundamental drivers: connection to purpose, strategic clarity, leadership alignment and focused action.
Sixteen measures — based on more than 50 data points per organization and spanning these four fundamental drivers — are examined, resulting in an overall score and a score by fundamental for each company, according to Indiggo. The 16 measures are then weighted using the Analytical Hierarchy Process to determine each company’s overall ROL score and ranking. Read more about the methodology here.
The 17 healthcare companies that cracked the ROL100, along with their ranking:
No. 10: Johnson & Johnson
No. 13: Merck
No. 20: Pfizer
No. 23: AbbVie
No. 24: UnitedHealth Group
No. 26: Bristol-Myers Squibb
No. 29: McKesson
No. 34: Elevance Health
No. 36: Humana
No. 41: Cigna
No. 44: HCA Healthcare
No. 47: Thermo Fisher Scientific
No. 69: Centene
No. 73: Cencora
No. 80: Cardinal Health
No. 93: CVS Health
No. 95: Walgreens Boots Alliance
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
